UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 161 filers reported holding UNIQURE NV in Q3 2019. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $64,453,000 | -4.6% | 1,750,000 | +16.7% | 0.92% | -31.4% |
| Q2 2020 | $67,590,000 | -13.7% | 1,500,000 | -9.1% | 1.34% | -49.5% |
| Q1 2020 | $78,293,000 | -35.7% | 1,650,000 | -2.9% | 2.64% | -26.1% |
| Q4 2019 | $121,822,000 | +748.0% | 1,700,000 | +365.8% | 3.58% | +497.2% |
| Q3 2019 | $14,366,000 | +802.4% | 365,000 | +438.7% | 0.60% | +688.2% |
| Q1 2018 | $1,592,000 | -71.1% | 67,758 | -70.1% | 0.08% | -96.4% |
| Q1 2015 | $5,507,000 | – | 226,456 | – | 2.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |